<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#336fb7"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007b83"/>
	<fontspec id="font2" size="9" family="Courier" color="#007b83"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#231f20"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="16" family="SymbolMT" color="#000000"/>
	<fontspec id="font11" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font14" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font16" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="503" width="51" height="10" font="font4" id="p1_t2" reading_order_no="50" segment_no="21" tag_type="text">Page 1 of 13<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="51" segment_no="22" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="157" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">BMC Cancer</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="86" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research article<b>BMC Cancer</b></text>
<text top="105" left="55" width="406" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">Growth regulation of simian and human AIDS-related<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="118" left="55" width="408" height="20" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">non-Hodgkin's lymphoma cell lines by TGF- Î² 1 and IL-6</text>
<text top="140" left="55" width="317" height="14" font="font11" id="p1_t9" reading_order_no="6" segment_no="5" tag_type="text">Kristin R Ruff, Adriane Puetter and Laura S Levy*<b>Growth regulation of simian and human AIDS-related </b></text>
<text top="176" left="55" width="477" height="8" font="font12" id="p1_t10" reading_order_no="7" segment_no="6" tag_type="text">Address: Department of Microbiology &amp; Immunology and Tulane Cancer Center, Tulane University Health Sciences Center, New Orleans,<b>non-Hodgkin's lymphoma cell lines by TGF-</b></text>
<text top="185" left="55" width="53" height="8" font="font12" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Louisiana, USA</text>
<text top="200" left="55" width="407" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="7" tag_type="text">Email: Kristin R Ruff - kris_ruff@yahoo.com; Adriane Puetter - adi.puetter@gmx.de; Laura S Levy* - llevy@tulane.edu<b>1 and IL-6</b></text>
<text top="211" left="55" width="92" height="8" font="font12" id="p1_t13" reading_order_no="10" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="359" left="112" width="44" height="10" font="font13" id="p1_t14" reading_order_no="20" segment_no="16" tag_type="title">Abstract</text>
<text top="374" left="112" width="385" height="9" font="font14" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">Background: AIDS-related non-Hodgkin's lymphoma (AIDS-NHL) is the second most frequent</text>
<text top="386" left="112" width="386" height="9" font="font15" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">cancer associated with AIDS, and is a frequent cause of death in HIV-infected individuals.</text>
<text top="398" left="112" width="386" height="9" font="font15" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">Experimental analysis of AIDS-NHL has been facilitated by the availability of an excellent animal<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17324269">  </a></text>
<text top="409" left="112" width="386" height="9" font="font15" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">model, i.e., simian Acquired Immunodeficiency Syndrome (SAIDS) in the rhesus macaque<b>Abstract</b></text>
<text top="421" left="112" width="386" height="9" font="font15" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">consequent to infection with simian immunodeficiency virus. A recent study of SAIDS-NHL<b>Background: </b></text>
<text top="433" left="112" width="385" height="9" font="font15" id="p1_t20" reading_order_no="26" segment_no="17" tag_type="text">demonstrated a lymphoma-derived cell line to be sensitive to the growth inhibitory effects of the</text>
<text top="445" left="112" width="386" height="9" font="font15" id="p1_t21" reading_order_no="27" segment_no="17" tag_type="text">ubiquitous cytokine, transforming growth factor-beta (TGF-beta). The authors concluded that</text>
<text top="456" left="112" width="386" height="9" font="font15" id="p1_t22" reading_order_no="28" segment_no="17" tag_type="text">TGF-beta acts as a negative growth regulator of the lymphoma-derived cell line and, potentially, as</text>
<text top="468" left="112" width="385" height="9" font="font15" id="p1_t23" reading_order_no="29" segment_no="17" tag_type="text">an inhibitory factor in the regulatory network of AIDS-related lymphomagenesis. The present study</text>
<text top="480" left="112" width="386" height="9" font="font15" id="p1_t24" reading_order_no="30" segment_no="17" tag_type="text">was conducted to assess whether other SAIDS-NHL and AIDS-NHL cell lines are similarly sensitive</text>
<text top="492" left="112" width="386" height="9" font="font15" id="p1_t25" reading_order_no="31" segment_no="17" tag_type="text">to the growth inhibitory effects of TGF-beta, and to test the hypothesis that interleukin-6 (IL-6)</text>
<text top="503" left="112" width="298" height="9" font="font15" id="p1_t26" reading_order_no="32" segment_no="17" tag_type="text">may represent a counteracting positive influence in their growth regulation.</text>
<text top="520" left="112" width="385" height="9" font="font14" id="p1_t27" reading_order_no="33" segment_no="18" tag_type="text">Methods: Growth stimulation or inhibition in response to cytokine treatment was quantified using</text>
<text top="532" left="112" width="386" height="9" font="font15" id="p1_t28" reading_order_no="34" segment_no="18" tag_type="text">trypan blue exclusion or colorimetric MTT assay. Intracellular flow cytometry was used to analyze</text>
<text top="544" left="112" width="385" height="9" font="font15" id="p1_t29" reading_order_no="35" segment_no="18" tag_type="text">the activation of signaling pathways and to examine the expression of anti-apoptotic proteins and</text>
<text top="555" left="112" width="386" height="9" font="font15" id="p1_t30" reading_order_no="36" segment_no="18" tag_type="text">distinguishing hallmarks of AIDS-NHL subclass. Apoptosis was quantified by flow cytometric</text>
<text top="567" left="112" width="364" height="9" font="font15" id="p1_t31" reading_order_no="37" segment_no="18" tag_type="text">analysis of cell populations with sub-G1 DNA content and by measuring activated caspase-3.</text>
<text top="584" left="112" width="385" height="9" font="font14" id="p1_t32" reading_order_no="38" segment_no="19" tag_type="text">Results: Results confirmed the sensitivity of LCL8664, an immunoblastic SAIDS-NHL cell line, to<b>Methods: </b></text>
<text top="596" left="112" width="386" height="9" font="font15" id="p1_t33" reading_order_no="39" segment_no="19" tag_type="text">TGF-beta1-mediated growth inhibition, and further demonstrated the partial rescue by</text>
<text top="607" left="112" width="386" height="9" font="font15" id="p1_t34" reading_order_no="40" segment_no="19" tag_type="text">simultaneous treatment with IL-6. IL-6 was shown to activate STAT3, even in the presence of TGF-</text>
<text top="619" left="112" width="385" height="9" font="font15" id="p1_t35" reading_order_no="41" segment_no="19" tag_type="text">beta1, and thereby to activate proliferative and anti-apoptotic pathways. By comparison, human</text>
<text top="631" left="112" width="386" height="9" font="font15" id="p1_t36" reading_order_no="42" segment_no="19" tag_type="text">AIDS-NHL cell lines differed in their responsiveness to TGF-beta1 and IL-6. Analysis of a recently</text>
<text top="643" left="112" width="386" height="9" font="font15" id="p1_t37" reading_order_no="43" segment_no="19" tag_type="text">derived AIDS-NHL cell line, UMCL01-101, indicated that it represents immunoblastic AIDS-</text>
<text top="654" left="112" width="385" height="9" font="font15" id="p1_t38" reading_order_no="44" segment_no="19" tag_type="text">DLCBL. Like LCL-8664, UMCL01-101 was sensitive to TGF-beta1-mediated inhibition, rescued<b>Results: </b></text>
<text top="666" left="112" width="385" height="9" font="font15" id="p1_t39" reading_order_no="45" segment_no="19" tag_type="text">partially by IL-6, and demonstrated rapid STAT3 activation following IL-6 treatment even in the</text>
<text top="678" left="112" width="94" height="9" font="font15" id="p1_t40" reading_order_no="46" segment_no="19" tag_type="text">presence of TGF-beta1.</text>
<text top="695" left="112" width="386" height="9" font="font14" id="p1_t41" reading_order_no="47" segment_no="20" tag_type="text">Conclusion: These studies indicate that the sensitivity of immunoblastic AIDS- or SAIDS-DLBCL</text>
<text top="706" left="112" width="385" height="9" font="font15" id="p1_t42" reading_order_no="48" segment_no="20" tag_type="text">to TGF-beta1-mediated growth inhibition may be overcome through the stimulation of</text>
<text top="718" left="112" width="384" height="9" font="font15" id="p1_t43" reading_order_no="49" segment_no="20" tag_type="text">proliferative and anti-apoptotic signals by IL-6, particularly through the rapid activation of STAT3.</text>
<text top="254" left="55" width="92" height="7" font="font16" id="p1_t44" reading_order_no="11" segment_no="9" tag_type="text">Published: 26 February 2007</text>
<text top="268" left="55" width="75" height="7" font="font17" id="p1_t45" reading_order_no="12" segment_no="12" tag_type="text">BMC Cancer 2007, 7 :35</text>
<text top="268" left="139" width="92" height="7" font="font16" id="p1_t46" reading_order_no="13" segment_no="12" tag_type="text">doi:10.1186/1471-2407-7-35</text>
<text top="254" left="310" width="93" height="7" font="font16" id="p1_t47" reading_order_no="18" segment_no="10" tag_type="text">Received: 8 November 2006</text>
<text top="263" left="310" width="92" height="7" font="font16" id="p1_t48" reading_order_no="19" segment_no="11" tag_type="text">Accepted: 26 February 2007<b>Conclusion: </b></text>
<text top="282" left="55" width="248" height="7" font="font16" id="p1_t49" reading_order_no="14" segment_no="13" tag_type="text">This article is available from: http://www.biomedcentral.com/1471-2407/7/35</text>
<text top="297" left="55" width="155" height="7" font="font16" id="p1_t50" reading_order_no="15" segment_no="14" tag_type="text">Â© 2007 Ruff et al; licensee BioMed Central Ltd.</text>
<text top="306" left="55" width="492" height="7" font="font16" id="p1_t51" reading_order_no="16" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),</text>
<text top="315" left="55" width="400" height="7" font="font16" id="p1_t52" reading_order_no="17" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
